July 12, 2013
Daiichi Sankyo began on July 8 voluntarily recalling its hyperlipidemia treatment Mevalotin Fine Granules 1% (pravastatin) after discovering that small amounts of the company’s vitamin product was mixed with the drug. The company will recall a total of 2,747 bottles,...read more